Some advocates have raised alarms about the experiments, suggesting that hybrids could develop that might be even more difficult to control.
Earlier this month, the EPA cleared the UK-based biotech company Oxitec to release a maximum of roughly 2.4bn of its genetically modified mosquitoes through 2024, expand its existing trial in Florida and start a new pilot project in California’s Central Valley, where mosquito numbers are on the rise.
Oxitec’s modified mosquitoes are male, and therefore don’t bite. They were developed with a special protein so that when they pair with a female mosquito the only viable offspring they produce are also non-biting males. The project specifically targets the Aedes aegypti mosquito, one of more than 3,500 mosquito species and a dangerous invasive insect that has spread diseases like dengue, Zika, Chikungunya, and yellow fever in other countries.Continue reading… “US poised to release 2.4bn genetically modified male mosquitoes to battle deadly diseases”